Related content

Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin

By Momi S.   Emerson M.   Paul W.   Leone M.   Mezzasoma A.M.   Del Soldato P.   Page C.P.   Gresele P.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin

By Chiroli V.   Benedini F.   Ongini E.   Del Soldato P.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 441-446

Elsevier

Access to resources Recommend Favorite

Mucosal injury associated with NCX 4016 is less than that of aspirin

By  

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat

By Wenk G.L.   Rosi S.   McGann K.   Hauss-Wegrzyniak B.  

European Journal of Pharmacology, Vol. 453, Iss. 2, 2002-10 ,pp. : 319-324

Elsevier

Access to resources Recommend Favorite

Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks

By  

Current Medicinal Chemistry, Vol. 17, Iss. 1, 2010-01 ,pp. : 61-73

Bentham Science Publishers

Access to resources Recommend Favorite